|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.9 NOK | +1.70% |
|
0.00% | +2.58% |
| Apr. 24 | Vistin Pharma ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 24 | Transcript : Vistin Pharma ASA, Q1 2024 Earnings Call, Apr 24, 2024 |
Vistin Pharma ASA reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was NOK 110.72 million compared to NOK 110.93 million a year ago. Net income was NOK 18.03 million compared to NOK 16.93 million a year ago.
Basic earnings per share from continuing operations was NOK 0.41 compared to NOK 0.38 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.58% | 95.97M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
VISTIN PHARMA ASA 
